Immunologic responses to bacteriophage ϕX 174 in immunodeficiency diseases
Open accessThe DOI matches its Crossref record.
Abstract
Immunologic responses to bacteriophage varphiX 174 were studied in 26 patients with immunodeficiency diseases. In eight cases of infantile X-linked agammaglobulinemia, there was prolonged circulation of phage and no detectable antibody response. The remaining 18 patients cleared phage normally and produced antibodies. 10 of these patients made only IgM antibody in spite of repeated immunization; all of these have recurrent respiratory tract infections and require treatment with gamma globulin and antibiotics. Eight patients made both IgM and IgG antibody; they experience either milder or no infections, and only one requires treatment with gamma globulin. Prolonged circulation of bacteriophage varphiX 174 and the absence of a detectable antibody response appear to be distinguishing characteristics of X-linked agammaglobulinemia if severe combined immunodeficiency can be excluded.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Rituximab, B-lymphocyte depletion, and preservation of beta-cell function
Pescovitz, M. D., Greenbaum, C. J., Krause-Steinrauf, H., Becker, D. J., Gitelman, S. E., Goland, R., Gottlieb, P. A., Marks, J. B., McGee, P. F., Moran, A. M., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0904452 · Cited by 1,093
The Primary Immunodeficiencies
Rosen, F. S., Cooper, M. D., & Wedgwood, R. J. P. (1984) · New England Journal of Medicine · doi:10.1056/nejm198408023110506 · Cited by 1,077
Self-citationAruffo, A., Farrington, M., Hollenbaugh, D., Li, X., Milatovich, A., Nonoyama, S., Bajorath, J., Grosmaire, L. S., Stenkamp, R., Neubauer, M., et al. (1993) · Cell · doi:10.1016/0092-8674(93)90668-g · Cited by 814
Self-citationWarnatz, K., Denz, A., Dräger, R., Braun, M., Groth, C., Wolff-Vorbeck, G., Eibel, H., Schlesier, M., & Peter, H. H. (2002) · Blood · doi:10.1182/blood.v99.5.1544 · Cited by 626
CTLA4Ig-mediated blockade of T-cell costimulation in patients with psoriasis vulgaris
Abrams, J. R., Lebwohl, M. G., Guzzo, C. A., Jegasothy, B. V., Goldfarb, M. T., Goffe, B. S., Menter, A., Lowe, N. J., Krueger, G., Brown, M. J., et al. (1999) · Journal of Clinical Investigation · doi:10.1172/jci5857 · Cited by 597
Self-citationOrange, J. S., Ballow, M., Stiehm, E. R., Ballas, Z. K., Chinen, J., De La Morena, M., Kumararatne, D., Harville, T. O., Hesterberg, P., Koleilat, M., et al. (2012) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2012.07.002 · Cited by 456
Interactions between Bacteriophage, Bacteria, and the Mammalian Immune System
Van Belleghem, J. D., Dąbrowska, K., Vaneechoutte, M., Barr, J. J., & Bollyky, P. L. (2018) · Viruses · doi:10.3390/v11010010 · Cited by 408
“Most studies suggest that it is very easy to generate phage antisera by immunization of humans or animals with phages [124,126,128,129].”
BackgroundDąbrowska, K. (2019) · Medicinal Research Reviews · doi:10.1002/med.21572 · Cited by 375
The prospect for bacteriophage therapy in Western medicine
Merril, C. R., Scholl, D., & Adhya, S. L. (2003) · Nature Reviews Drug Discovery · doi:10.1038/nrd1111 · Cited by 367
Biological Gene Delivery Vehicles: Beyond Viral Vectors
Seow, Y., & Wood, M. J. (2009) · Molecular Therapy · doi:10.1038/mt.2009.41 · Cited by 327
The Wiskott-Aldrich syndrome: studies of lymphocytes, granulocytes, and platelets
Ochs, H., Slichter, S., Harker, L., Von Behrens, W., Clark, R., & Wedgwood, R. (1980) · Blood · doi:10.1182/blood.v55.2.243.243 · Cited by 322
Self-citationCD40-CD40 Ligand: A Multifunctional Receptor-Ligand Pair
Van Kooten, C., & Banchereau, J. (1996) · Advances in Immunology · doi:10.1016/s0065-2776(08)60865-2 · Cited by 311
Pihoker, C., Gilliam, L. K., Hampe, C. S., & Lernmark, A. (2005) · Diabetes · doi:10.2337/diabetes.54.suppl_2.s52 · Cited by 303
The Primary Immunodeficiencies
Rosen, F. S., Cooper, M. D., & Wedgwood, R. J. P. (1984) · New England Journal of Medicine · doi:10.1056/nejm198407263110406 · Cited by 289
Self-citationWarnatz, K. (2006) · Blood · doi:10.1182/blood-2005-07-2955 · Cited by 281
Bacteriophage therapy and prophylaxis: rediscovery and renewed assessment of potential
Barrow, P. A., & Soothill, J. S. (1997) · Trends in Microbiology · doi:10.1016/s0966-842x(97)01054-8 · Cited by 280
Phage as a Modulator of Immune Responses
Górski, A., Międzybrodzki, R., Borysowski, J., Dąbrowska, K., Wierzbicki, P., Ohams, M., Korczak-Kowalska, G., Olszowska-Zaremba, N., Łusiak-Szelachowska, M., Kłak, M., et al. (2012) · Advances in Virus Research · doi:10.1016/b978-0-12-394438-2.00002-5 · Cited by 266
Witherspoon, R., Storb, R., Ochs, H., Fluornoy, N., Kopecky, K., Sullivan, K., Deeg, J., Sosa, R., Noel, D., Atkinson, K., et al. (1981) · Blood · doi:10.1182/blood.v58.2.360.360 · Cited by 265
Self-citationCD40 ligand expression is defective in a subset of patients with common variable immunodeficiency.
Farrington, M., Grosmaire, L. S., Nonoyama, S., Fischer, S. H., Hollenbaugh, D., Ledbetter, J. A., Noelle, R. J., Aruffo, A., & Ochs, H. D. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.3.1099 · Cited by 227
Self-citationBacteriophages and the Immune System
Popescu, M., Van Belleghem, J. D., Khosravi, A., & Bollyky, P. L. (2021) · Annual Review of Virology · doi:10.1146/annurev-virology-091919-074551 · Cited by 178
Contribution of the Immune Response to Phage Therapy
Krut, O., & Bekeredjian-Ding, I. (2018) · The Journal of Immunology · doi:10.4049/jimmunol.1701745 · Cited by 172
“Thus, more in-depth investigations are warranted to elucidate whether phage persistence due to lack of immune control (64) might favor selection of phage-resistant bacterial strains in vivo.”
BackgroundComparison of Diagnostic Criteria for Common Variable Immunodeficiency Disorder
Ameratunga, R., Brewerton, M., Slade, C., Jordan, A., Gillis, D., Steele, R., Koopmans, W., & Woon, S.-T. (2014) · Frontiers in Immunology · doi:10.3389/fimmu.2014.00415 · Cited by 161
“The ψx174 vaccine has not been registered by the FDA and cannot be used in routine clinical practice (67).”
BackgroundSafety and efficacy of phage therapy via the intravenous route
Speck, P., & Smithyman, A. (2016) · FEMS Microbiology Letters · doi:10.1093/femsle/fnv242 · Cited by 160
“Ochs and colleagues however have shown that it takes several days for PhiX-174 to be cleared from the bloodstream (Ochs et al., 1971), so the time of persistence of phages in the bloodstream compares favorably with that of antibiotics, many of which have bloodstream half-lives measured in hours.”
Background
Metadata
- Authors
- Ochs, H. D., Davis, S. D., & Wedgwood, R. J.
- Venue
- Journal of Clinical Investigation
- Published
- 1971-12-01
- Volume
- 50
- Issue
- 12
- Pages
- 2559-2568
- ISSN
- 0021-9738 (ISSN-L)
- OpenAlex
- W2101995737
- Cited by
- 219
- References
- 0
- FWCI
- 2.38
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.